These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target. Manolis AS; Manolis AA; Manolis TA; Melita H Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814 [TBL] [Abstract][Full Text] [Related]
24. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002 [TBL] [Abstract][Full Text] [Related]
25. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China]. Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275 [No Abstract] [Full Text] [Related]
26. Perspectives of drug-based neuroprotection targeting mitochondria. Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485 [TBL] [Abstract][Full Text] [Related]
27. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats. Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258 [TBL] [Abstract][Full Text] [Related]
28. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Melenovsky V; Petrak J; Mracek T; Benes J; Borlaug BA; Nuskova H; Pluhacek T; Spatenka J; Kovalcikova J; Drahota Z; Kautzner J; Pirk J; Houstek J Eur J Heart Fail; 2017 Apr; 19(4):522-530. PubMed ID: 27647766 [TBL] [Abstract][Full Text] [Related]
29. Cardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure. Thai PN; Daugherty DJ; Frederich BJ; Lu X; Deng W; Bers DM; Dedkova EN; Schaefer S Sci Rep; 2018 Nov; 8(1):16213. PubMed ID: 30385779 [TBL] [Abstract][Full Text] [Related]
30. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling. Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149 [TBL] [Abstract][Full Text] [Related]
31. Inducible NO synthase is constitutively expressed in porcine myocardium and its level decreases along with tachycardia-induced heart failure. Paslawska U; Kiczak L; Bania J; Paslawski R; Janiszewski A; Dzięgiel P; Zacharski M; Tomaszek A; Michlik K Cardiovasc Pathol; 2016; 25(1):3-11. PubMed ID: 26361649 [TBL] [Abstract][Full Text] [Related]
32. Left ventricular diastolic and systolic dyssynchrony and dysfunction in heart failure with preserved ejection fraction and a narrow QRS complex. Liu S; Guan Z; Jin X; Meng P; Wang Y; Zheng X; Jia D; Ma C; Yang J Int J Med Sci; 2018; 15(2):108-114. PubMed ID: 29333094 [No Abstract] [Full Text] [Related]
33. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs. Chen YT; Wong LL; Liew OW; Richards AM Cells; 2019 Dec; 8(12):. PubMed ID: 31888288 [TBL] [Abstract][Full Text] [Related]
34. The cellular and physiologic effects of beta blockers in heart failure. Sabbah HN Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699 [TBL] [Abstract][Full Text] [Related]
35. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression. Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803 [TBL] [Abstract][Full Text] [Related]
36. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462 [TBL] [Abstract][Full Text] [Related]
37. Cardiomyocyte-specific loss of RNA polymerase II subunit 5-mediating protein causes myocardial dysfunction and heart failure. Zhang J; Sheng J; Dong L; Xu Y; Yu L; Liu Y; Huang X; Wan S; Lan HY; Wang H Cardiovasc Res; 2019 Sep; 115(11):1617-1628. PubMed ID: 30590389 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction. Sun LY; Tu JV; Bader Eddeen A; Liu PP J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401 [TBL] [Abstract][Full Text] [Related]
39. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553 [TBL] [Abstract][Full Text] [Related]